Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology

다국어 초록 (Multilingual Abstract)

Previous concepts of immune-privileged sites obscured the role of peripheral immune cells in neurological disorders and excluded the consideration of the potential benefits of immunotherapy. Recently, however, numerous studies have demonstrated that the blood–brain barrier in the central nervous system is an educational barrier rather than an absolute barrier to peripheral immune cells. Emerging knowledge of immune-privileged sites suggests that peripheral immune cells can infiltrate these sites via educative gates and that crosstalk can occur between infiltrating immune cells and the central nervous system parenchyma.
This concept can be expanded to the testis, which has long been considered an immune-privileged site, and to neurogenic bladder dysfunction. Thus, we propose that the relationship between peripheral immune cells, the brain, and the urologic system should be considered as an additional possible mechanism in urologic diseases, and that immunotherapy might be an alternative therapeutic strategy in treating neurogenic bladder dysfunction.

참고문헌 (Reference)

1 Villeda SA, "Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice" 20 : 659-663, 2014

2 Benner EJ, "Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease" 101 : 9435-9440, 2004

3 Goyal HO, "The rete testis of the goat, a morphological study" 130 : 151-157, 1987

4 Naito M, "The presence of intra-tubular lymphocytes in normal testis of the mouse" 85 : 91-96, 2008

5 Kwon MS, "The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients" 131 : 206-218, 2014

6 Melfi CA, "The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression" 55 : 1128-1132, 1998

7 Mortazavi MM, "The choroid plexus: a comprehensive review of its history, anatomy, function, histology, embryology, and surgical considerations" 30 : 205-214, 2014

8 Robberecht W, "The changing scene of amyotrophic lateral sclerosis" 14 : 248-264, 2013

9 Kivisäkk P, "T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking" 129 : 510-518, 2002

10 Appel SH, "T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening?" 31 : 17-, 2010

11 Mitchell KJ, "Rethinking the genetic architecture of schizophrenia" 41 : 19-32, 2011

12 Henkel JS, "Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival" 5 : 64-79, 2013

13 Michaud JP, "Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta" 5 : 646-653, 2013

14 Teasdale JD, "Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy" 68 : 615-623, 2000

15 Oh KW, "Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis" 4 : 590-597, 2015

16 Dauer W, "Parkinson’s disease: mechanisms and models" 39 : 889-909, 2003

17 Shechter R, "Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates" 13 : 206-218, 2013

18 Benner EJ, "Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons" 3 : e1376-, 2008

19 Reynolds AD, "Nitrated [31]-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets" 182 : 4137-4149, 2009

20 Kipnis J, "Neuroprotective autoimmunity: naturally occurring CD4+CD25+regulatory T cells suppress the ability to withstand injury to the central nervous system" 99 : 15620-15625, 2002

21 Reynolds AD, "Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease" 82 : 1083-1094, 2007

22 Philips T, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease" 10 : 253-263, 2011

23 Trapp BD, "Multiple sclerosis: an immune or neurodegenerative disorder?" 31 : 247-269, 2008

24 Ransohoff RM, "Microglial physiology: unique stimuli, specialized responses" 27 : 119-145, 2009

25 Saijo K, "Microglial cell origin and phenotypes in health and disease" 11 : 775-787, 2011

26 Wake H, "Microglia: actively surveying and shaping neuronal circuit structure and function" 36 : 209-217, 2013

27 Miller BJ, "Metaanalysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects" 70 : 663-671, 2011

28 Belmaker RH, "Major depressive disorder" 358 : 55-68, 2008

29 Carvalho LA, "Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system" 148 : 136-140, 2013

30 Khandaker GM, "Is there a role for immune-to-brain communication in schizophrenia?" 233 : 1559-1573, 2016

31 Dantzer R, "Inflammationassociated depression: from serotonin to kynurenine" 36 : 426-436, 2011

32 Brochard V, "Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease" 119 : 182-192, 2009

33 Hodes GE, "Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress" 111 : 16136-16141, 2014

34 Medawar PB, "Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye" 29 : 58-69, 1948

35 Zhao W, "Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis" 8 : 888-899, 2013

36 Herberth M, "Identification of a molecular profile associated with immune status in first-onset schizophrenia patients" 7 : 207-215, 2014

37 Han A, "IL-4/10prevents stress vulnerability following imipramine discontinuation" 12 : 197-, 2015

38 Gordon PH, "How can we improve clinical trials in amyotrophic lateral sclerosis?" 7 : 650-654, 2011

39 Beers DR, "Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis" 134 (134): 1293-1314, 2011

40 Carrithers MD, "Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment" 123 (123): 1092-1101, 2000

41 Busse S, "Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia:further evidence for disease course-related immune alterations?" 26 : 1273-1279, 2012

42 Soler R, "Development of bladder dysfunction in a rat model of dopaminergic brain lesion" 30 : 188-193, 2011

43 Yirmiya R, "Depression as a microglial disease" 38 : 637-658, 2015

44 Mawuenyega KG, "Decreased clearance of CNS beta-amyloid in Alzheimer’s disease" 330 : 1774-, 2010

45 Upthegrove R, "Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis" 155 : 101-108, 2014

46 Provencio JJ, "Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients" 163 : 179-184, 2005

47 Durrenberger PF, "Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study" 122 : 1055-1068, 2015

48 Crystal C. Watkins, "Clinical studies of neuroinflammatory mechanisms in schizophrenia" Elsevier BV 176 (176): 14-22, 2016

49 Engelhardt B, "Capture, crawl, cross: the T cell code to breach the blood-brain barriers" 33 : 579-589, 2012

50 Castellano JM, "Blood-borne revitalization of the aged brain" 72 : 1191-1194, 2015

51 Paez-Colasante X, "Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era" 11 : 266-279, 2015

52 Kiernan MC, "Amyotrophic lateral sclerosis" 377 : 942-955, 2011

53 Spillantini MG, "Alpha-synuclein in Lewy bodies" 388 : 839-840, 1997

54 Baruch K, "Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function" 346 : 89-93, 2014

55 Debnath M, "Adaptive Immunity in schizophrenia: functional implications of t cells in the etiology, course and treatment" 10 : 610-619, 2015

56 Cho YS, "A novel intracerebral hemorrhage-induced rat model of neurogenic voiding dysfunction: Analysis of lower urinary tract function" 12 : 2563-2569, 2015

57 Dowlati Y, "A meta-analysis of cytokines in major depression" 67 : 446-457, 2010